BackAnthem Biosciences Overview

Anthem Biosciences Inventory

Latest inventory for ANTHEM.NS: $1.9B.

Get informed when a big investor buys or sells

+ Follow
Inventory
$1.89B
↑ 1.52% YoYΔ $28.27M vs prior year quarter

Peer trimmed avg / median

Loading

Anthem Biosciences Inventory History

Loading

Anthem Biosciences vs. peers: Inventory Comparison

Loading

Anthem Biosciences Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Anthem Biosciences (ANTHEM.NS) FAQ

The latest inventory for ANTHEM.NS is $1.9B as of September 2026. That compares with $1.9B in the prior-year period — up 1.5% year over year. Investors often review this figure alongside Anthem Biosciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, ANTHEM.NS's inventory moved from $1.9B to $1.9B — a 1.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Anthem Biosciences's operating scale or balance-sheet position.

A inventory figure of $1.9B for ANTHEM.NS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ANTHEM.NS's inventory ($1.9B), review year-over-year change from $1.9B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Anthem Biosciences's inventory against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.